Cargando…
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
Circulating tumor cells (CTCs) belong to a heterogeneous pool of rare cells, and a unequivocal phenotypic definition of CTC is lacking. Here, we present a definition of metabolically-altered CTC (MBA-CTCs) as CD45-negative cells with an increased extracellular acidification rate, detected with a sin...
Autores principales: | Brisotto, Giulia, Biscontin, Eva, Rossi, Elisabetta, Bulfoni, Michela, Piruska, Aigars, Spazzapan, Simon, Poggiana, Cristina, Vidotto, Riccardo, Steffan, Agostino, Colombatti, Alfonso, Huck, Wilhelm T. S., Cesselli, Daniela, Zamarchi, Rita, Turetta, Matteo, Del Ben, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226515/ https://www.ncbi.nlm.nih.gov/pubmed/32325824 http://dx.doi.org/10.3390/cancers12041005 |
Ejemplares similares
-
Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
por: Muraro, Elena, et al.
Publicado: (2022) -
Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
por: Turetta, Matteo, et al.
Publicado: (2018) -
Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models
por: Turetta, Matteo, et al.
Publicado: (2018) -
Possible role of circulating tumor cells in early detection of lung cancer
por: Poggiana, Cristina, et al.
Publicado: (2020) -
Probing single-cell metabolism reveals prognostic value of highly metabolically active circulating stromal cells in prostate cancer
por: Rivello, Francesca, et al.
Publicado: (2020)